<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-3EY9GD9O</identifier><date>2014</date><creator>Velenik, Vaneja</creator><relation>documents/doc/3/URN_NBN_SI_doc-3EY9GD9O_001.pdf</relation><relation>documents/doc/3/URN_NBN_SI_doc-3EY9GD9O_001.txt</relation><format format_type="issue">1</format><format format_type="volume">18</format><format format_type="type">article</format><format format_type="extent">str. 48-52, 75</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID">1807739</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-3EY9GD9O</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">požiralnik</subject><subject language_type_id="slv">prebavila</subject><subject language_type_id="slv">radiokemoterapija</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">želodec</subject><title>Ali imajo tarčna zdravila svoje mesto v radiokemoterapiji tumorjev prebavil?</title></Record>